The multidimensional role of SLC16A4 in hepatocellular carcinoma in silico analysis: prognostic significance, metabolic pathways, and immune microenvironment regulation
SLC16A4 exhibits cancer-specific expression patterns and plays a multifaceted role in tumor progression, metabolism, and immune regulation. Its potential as a diagnostic and prognostic biomarker, particularly in LIHC, warrants further investigation. These findings highlight SLC16A4 as a promising target for future cancer research and therapy.
Authors
- Lili Jiang (ORCID: https://orcid.org/0000-0002-7021-371X)
- Qiliang Peng (ORCID: https://orcid.org/0000-0002-0248-8826)
- Zhengyang Feng
- Yunxia Zhu (ORCID: https://orcid.org/0000-0002-4597-4445)
- Yi Shen (ORCID: https://orcid.org/0000-0001-5683-2090)
- Yong Wang
- Yuntian Shen
Institutions
- Nantong University (CN)
- Soochow University (CN)
- Second People's Hospital of NanTong (CN)
- Suzhou Municipal Hospital (CN)
- Second Affiliated Hospital of Soochow University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1186/s40001-025-03275-y
- Citations
- 2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.61